120 related articles for article (PubMed ID: 151899)
1. Clinical investigations of neocarzinostatin in Japan.
Kimura I
Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
[TBL] [Abstract][Full Text] [Related]
2. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer.
Sakamoto S; Ogata J; Ikegami K; Maeda H
Cancer Treat Rep; 1978 Mar; 62(3):453-4. PubMed ID: 148320
[No Abstract] [Full Text] [Related]
3. Zinostatin (neocarzinostatin).
Issell BF; Prestayko AW; Comis RL; Crooke ST
Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
[No Abstract] [Full Text] [Related]
4. Neocarzinostatin in cancer chemotherapy (review).
Maeda H
Anticancer Res; 1981; 1(3):175-86. PubMed ID: 6211130
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration.
Sakamoto S; Ogata J; Ikegami K; Maeda H
Eur J Cancer (1965); 1980 Jan; 16(1):103-13. PubMed ID: 6444585
[No Abstract] [Full Text] [Related]
6. Neocarzinostatin (NSC 157365) a new cancerostatic compound.
Legha SS; Von Hoff DD; Rozencweig M; Abraham D; Slavik M; Muggia M
Oncology; 1976; 33(5-6):265-70. PubMed ID: 141012
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.
Maeda H; Sakamoto S; Ogata J
Antimicrob Agents Chemother; 1977 Jun; 11(6):941-5. PubMed ID: 141906
[TBL] [Abstract][Full Text] [Related]
8. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.
Otsuji E; Takahashi T; Yamaguchi T; Yamaguchi N; Imanishi J
Gastroenterol Jpn; 1990 Apr; 25(2):244-8. PubMed ID: 2140808
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of neocarzinostatin in digestive system cancer. 2. Clinical studies on the administration of neocarzinostatin in advanced and recurrent carcinoma of the pancreas].
Kikuchi K; Kusama S; Furue H; Muto T; Toriyama K; Wakiya M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1872-7. PubMed ID: 6224466
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute leukemia with neocarzinostatin (NCS)].
Masaoka T; Nakamura H; Hasegawa Y; Shibata H; Tatsumi N
Rinsho Ketsueki; 1974 Dec; 15(12):1309-16. PubMed ID: 4282747
[No Abstract] [Full Text] [Related]
11. Neocarzinostatin: initial clinical and pharmacologic studies in the United States.
Comis RL; Griffin T; Raso V; Ginsberg SJ
Recent Results Cancer Res; 1978; 63():261-71. PubMed ID: 151900
[No Abstract] [Full Text] [Related]
12. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
Shimoyama M; Kimura K
Gan; 1979 Apr; 70(2):165-71. PubMed ID: 157307
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of neocarzinostatin in patients with acute leukemia.
Van Echo DA; Wiernik PH
Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
[No Abstract] [Full Text] [Related]
14. [The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)].
Kitajima K
Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):767-72. PubMed ID: 4282818
[No Abstract] [Full Text] [Related]
15. Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody-drug conjugate.
Okamoto K; Yamaguchi T; Otsuji E; Yamaoka N; Yata Y; Tsuruta H; Kitamura K; Takahashi T
Cancer Lett; 1998 Jan; 122(1-2):231-6. PubMed ID: 9464516
[TBL] [Abstract][Full Text] [Related]
16. Neocarzinostatin: a new agent active in the treatment of acute leukemia.
Kitajima K; Kamimura O; Nagao T; Takahashi I; Hiraki K
Bibl Haematol; 1975; (40):751-2. PubMed ID: 126059
[No Abstract] [Full Text] [Related]
17. [Neocarzinostatin therapy of advanced renal cell carcinoma].
Tari K; Satake I; Kojima S; Tsujii T; Yonese J
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
[TBL] [Abstract][Full Text] [Related]
18. [Screening for antagonistic agents to the lethal toxicity of neocarzinostatin. II. Effects of various drugs in inhibiting the toxicity of neocarzinostatin in vivo].
Ouchi M; Toriyama K; Matsumoto T; Baba T
Jpn J Antibiot; 1988 Jan; 41(1):105-15. PubMed ID: 2966869
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot study.
Falkson G; Von Hoff D; Klaassen D; Du Plessis H; Van Der Merwe CF; Van Der Merwe AM; Carbone PP
Cancer Chemother Pharmacol; 1980; 4(1):33-6. PubMed ID: 6244904
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of pancreatic carcinoma with neocarzinostatin].
Kinami Y; Miyazaki H; Koyama F; Noguchi M; Konishi K
Nihon Gan Chiryo Gakkai Shi; 1975 Dec; 10(4):502-8. PubMed ID: 130432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
